UnitedHealth, medical costs
Digest more
UnitedHealth Group Incorporated is rated Buy following solid Q3 earnings beat & signs of operational recovery. Learn more about UNH stock here.
UnitedHealth Group's third quarter revenues grew 12% to $113.2 billion, but headwinds have created challenges for the company, with CEO Stephen Helmsley saying there was a “key sense of urgency” across the company to return to performance standards.
UnitedHealth Group (NYSE: UNH) beat earnings expectations this morning, posting adjusted EPS of $2.92 against a consensus of $2.82. The stock opened near $379, buoyed by the EPS beat and a raised full-year guidance.
Q3 2025 Management View CEO Stephen Hemsley reported "introducing new leaders, strengthening underperforming businesses, identifying both opportunities and inefficiencies and importantly, recommitting to the mission and culture of this company.
For the third quarter, UnitedHealth reported adjusted earnings per share of $2.92 compared with $7.15 a year earlier. Revenue rose to $113.2 billion from $100.8 billion.
UnitedHealth Group’s third quarter profit beat investor expectations and prompted the company to increase its earnings outlook for the year, even though the result reported Tuesday was less than half the earnings seen during the same period last year.
UnitedHealth Group (UNH) remains a solid Buy despite valuation risks. UNH remains the most expensive among peers. See more analysis here.
As CEO Stephen Hemsley nears six months in control of UnitedHealth Group, the health insurer is making the financial turnaround he promised.
Shares in industry giant UnitedHealth Group rose before market open as the company boosted its guidance for the year. | Shares in industry giant UnitedHealth Group rose before market open as the company boosted its guidance for the year.
News Nation on MSN
UnitedHealth faces scrutiny over nursing home practices
Democratic Sens. Elizabeth Warren and Ron Wyden demanded the insurance company hand over relevant records by September.
UnitedHealth stock is down 28% this year, but news of Berkshire Hathaway’s stake gave it a boost in August. What to look for in the healthcare provider’s earnings report.
Feedback